Gainers & Losers
Mon Nov 25 2024 10:23:34- Larsen & Toubro share price
- ₹3,753.254.13%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
- Wipro share price
- ₹582.751.99%
- ICICI Bank share price
- ₹1,301.501.82%
Active Stocks
Mon Nov 25 2024 10:27:51- Adani Power share price
- ₹446.85-3.02%
- Power Grid Corporation Of ...
- ₹342.851.74%
- Tata Steel share price
- ₹143.600.56%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
Business News/Market/Market Stats/Strides Pharma Science share price/ Strides Pharma Science Profit Loss Annual
Strides Pharma Science Profit & Loss Annual
Trade1,419.15 -84.60 (-5.63%)Updated : 25 Nov 2024
| Fiscal Period | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
| Revenue | 4,051.12 | 3,688.39 | 3,070.25 | 3,315.87 |
| Total Revenue | 4,051.12 | 3,688.39 | 3,070.25 | 3,315.87 |
| Costof Revenue Total | 1,640.51 | 1,831.67 | 1,703.09 | 1,518.72 |
| Gross Profit | 2,410.62 | 1,856.72 | 1,367.16 | 1,797.15 |
| Selling/ General/ Admin Expenses Total | 751.13 | 1,434.40 | 1,351.70 | 1,150.49 |
| Depreciation/ Amortization | 220.68 | 242.56 | 230.46 | 201.72 |
| Unusual Expense( Income) | 189.05 | 17.03 | 299.53 | -11.05 |
| Other Operating Expenses Total | 916.23 | 35.13 | 19.75 | 12.15 |
| Total Operating Expense | 3,717.59 | 3,561.48 | 3,607.08 | 2,876.59 |
| Operating Income | 333.54 | 126.91 | -536.83 | 439.28 |
| Interest Inc( Exp) Net- Non- Op Total | -4,901.81 | -3,833.96 | -1,029.34 | -1,451.29 |
| Other Net | 39.70 | -33.82 | -23.99 | -21.05 |
| Net Income Before Taxes | -116.94 | -286.20 | -652.51 | 275.44 |
| Provisionfor Income Taxes | 31.59 | -55.30 | -178.26 | 31.65 |
| Net Income After Taxes | -148.53 | -230.90 | -474.25 | 243.79 |
| Minority Interest | 23.70 | 9.70 | 14.04 | 10.71 |
| Net Income Before Extra Items | -124.83 | -221.20 | -460.21 | 254.50 |
| Total Extraordinary Items | 54.22 | 18.57 | 0.00 | 13.94 |
| Net Income | -70.61 | -202.64 | -460.21 | 268.44 |
| Income Availableto Com Excl Extra Ord | -124.83 | -221.20 | -460.21 | 254.50 |
| Income Availableto Com Incl Extra Ord | -70.61 | -202.64 | -460.21 | 268.44 |
| Diluted Net Income | -70.61 | -202.64 | -460.21 | 268.44 |
| Diluted Weighted Average Shares | 9.10 | 9.01 | 8.97 | 8.97 |
| Diluted EPS Excluding Extra Ord Items | -13.72 | -24.56 | -51.28 | 28.37 |
| DPS- Common Stock Primary Issue | 2.50 | 1.50 | 0.00 | 2.50 |
| Diluted Normalized EPS | -0.21 | -23.62 | -30.40 | 27.05 |
| Interest Exp( Inc) Net- Operating Total | - | 6.89 | 25.59 | 45.67 |
| Gain( Loss)on Saleof Assets | - | 41.07 | 112.47 | 23.38 |
*All figures in crores except per share values
Strides Pharma Science Quick Links
Strides Pharma Science Dividend Strides Pharma Science Bonus Strides Pharma Science News Strides Pharma Science AGM Strides Pharma Science Rights Strides Pharma Science Splits Strides Pharma Science Board Meetings Strides Pharma Science Key Metrics Strides Pharma Science Shareholdings Strides Pharma Science Balance Sheet Strides Pharma Science Cashflow Strides Pharma Science Q1 Results Strides Pharma Science Q2 Results Strides Pharma Science Q3 Results Strides Pharma Science Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
3,753.25+148.70(4.13%)
844.75+28.70(3.52%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)